首页> 外国专利> method for preparation of new carboalkoxy ge substitueerde chinoxaline - 1.4 - dioxyden, method for preparation of the pharmaceutical preparations.as to the products thus formed.

method for preparation of new carboalkoxy ge substitueerde chinoxaline - 1.4 - dioxyden, method for preparation of the pharmaceutical preparations.as to the products thus formed.

机译:新的碳烷氧基取代基氧杂环丁烷-1.4-二氧杂环丁烷的制备方法,药物制剂的制备方法。

摘要

1330151 Quinoxaline-1,4-dioxides PFIZER Inc 3 Nov 1970 [18 March 1970 (2)] 52312/70 Heading C2C Novel compounds I, II and IIA in which X is a 6- or 7-position substituent and is H, Cl, Br, F, CH 3 , CH 3 O or CF 3 ; R 2 is 1-4 C alkyl, R 4 is 1-3 C alkyl; Z is Cl or Br; ZSP1/SP is OH, OCOR, NH 2 , NHR 1 or NR 3 R 5 ; R is H, 1-3 C alkyl, phenyl, alkoxyphenyl or dialkylaminophenyl; R 1 is 1-4 C alkyl, benzoyl or substituted benzoyl; R 3 and R 5 are 1-2 C alkyl; Y is O, S or NR 6 ; R 6 is H or 1-4 C alkyl; and A is alkylene of 2-5 C which places at least 2 C between N and Y, N and Z or O and ZSP1/SP or A is part of a 3-8 C cycloalkylene (A may be substituted by OH), are prepared (a) by reaction of an appropriate benzofuroxan with a compound III or IV: a compound H 2 N-A-Z(HZ) m (m=0 or 1) and diketene; a compound R 4 COCH 2 COOAZSP1/SP; a compound R 4 -CO-CH 2 -CO-O-A-NR 1 - COO t-alkyl followed by hydrolysis; or a compound R 4 -CH 2 -CO-CO 2 -A-ZSP1/SP; or (b) by reaction of a compound IX or XI with HO-A-ZSP1/SP; or (c) by reaction of an X- substituted -2-cyano-3-R 2 -quinoxaline 1,4-dioxide with H 2 N-A-SH or H 2 N-A-NHR 6 - C 7 H 7 -SO 3 H; or (d) by reaction of an X-substituted-2-amido ether HCl-3-R 2 -quinoxaline- 1,4-dioxide with an appropriate alkylene diamine or thioalkylamine; or (e) by cyclizing compounds II to give compounds I. 2 - (Acetyloxy)ethyl - acetoacetate is prepared by reaction of 2-hydroxyethyl acetate and diketene. Other compounds CH 3 COCH 2 CO 2 AZSP1/SP are similarly prepared. N - (2 - Bromoethyl)acetoacetamide is prepared by reaction of diketene with 2-bromoethylamine HBr. Compounds CH 3 CO.CH 2 CO 2 -A-NR 3 R 5 are prepared by reaction of diketene and R 3 R 5 NA-OH. Compounds XII are prepared by reaction of the appropriate benzofuroxan with Compounds are prepared by reaction of diketene with HOA-NR 1 -COOC(CH 3 ) 3 . Compounds HO-A-ZSP1/SP where ZSP1/SP is -O 2 CR, are prepared by reaction of HO-A-OH with an appropriate amide. Compounds HO-A-ZSP1/SP where ZSP1/SP is substituted amino, are prepared by reaction of HO-A-halogen with an appropriate amine. Compounds NH 2 -A-Cl.HCl are prepared by reaction of NH 2 -A-OH.HCl with SOCl 2 . Compounds R 4 COCH 2 CO 2 -A-ZSP1/SP are prepared by the reaction of Dorsch et al., J. Am. Chem. Soc., 54, 2960 (1932). Compounds XIII are prepared by reaction of the appropriate 2 - methyl - 1,3 - oxazacyclic compound with R 4 COCl in the presence of n-butyl-lithium. Compounds XIV are prepared by reaction of HOANH 2 with acetic acid. Compounds XV are prepared by reaction of H 2 N-A-NHR 1 with acetic acid. Compounds XVI are prepared by reaction of Cl-A-Cl with thioacetamide. Compounds XVII are prepared by reaction of the 2-cyano compounds with ethanol. Compounds XVIII are prepared by reaction of the 2-methyl compound with R 2 COCl and n-butyl lithium. Compounds XIX are prepared by reaction of R 2 COCH 2 CN with an appropriate benzofuroxan. Pharmaceutical compositions comprise a compound I, II or IIA together with a suitable carrier and are useful as antibacterial agents.
机译:1330151喹喔啉-1,4-二氧化物PFIZER Inc 1970年11月3日[1970年3月18日(2)] 52312/70标题C2C其中X为6或7位取代基且为H,Cl的新型化合物I,II和IIA ,Br,F,CH 3,CH 3 O或CF 3; R 2为1-4个碳原子的烷基,R 4为1-3个碳原子的烷基; Z为Cl或Br; Z 1 是OH,OCOR,NH 2,NHR 1或NR 3 R 5; R是H,1-3个碳的烷基,苯基,烷氧基苯基或二烷基氨基苯基; R 1为1-4个碳的烷基,苯甲酰基或取代的苯甲酰基; R 3和R 5为1-2个碳原子的烷基; Y为O,S或NR 6; R 6为H或1-4个碳的烷基;并且A为2-5 C的亚烷基,其在N与Y,N与Z或O和Z 1 之间至少存在2 C,或A为3-8 C环亚烷基的一部分(A可为(a)通过合适的苯并呋喃与化合物III或IV的反应制备:(a)化合物H 2 NAZ(HZ)m(m = 0或1)和双烯酮;化合物R 4 COCH 2 COOAZ 1 ;化合物R 4 -CO-CH 2 -CO-O-A-NR 1 -COO叔烷基,然后水解;或化合物R 4 -CH 2 -CO-CO 2 -A-Z 1 ; (b)使化合物或与HO-A-Z 1 反应;或(c)通过X-取代的-2-氰基-3-R 2-喹喔啉1,4-二氧化物与H 2 N-A-SH或H 2 N-A-NHR 6 -C 7 H 7 -SO 3 H反应;或(d)使X-取代的2-氨基醚HCl-3-R 2-喹喔啉-1,4-二氧化物与适当的亚烷基二胺或硫代烷基胺反应;或(e)通过将化合物II环化得到化合物I。2-(乙酰氧基)乙基-乙酰乙酸酯是通过乙酸2-羟乙基酯与二烯酮的反应制备的。类似地制备其他化合物CH 3 COCH 2 CO 2 AZ 1 。通过使二酮烯与2-溴乙胺HBr反应来制备N-(2-溴乙基)乙酰乙酰胺。化合物CH 3 CO.CH 2 CO 2 -A-NR 3 R 5是通过双烯酮与R 3 R 5 NA-OH反应制备的。化合物XII是通过适当的苯并呋喃恶烷与二烯酮与HOA-NR 1 -COOC(CH 3)3反应制备的。化合物HO-A-Z 1 ,其中Z 1 为-O 2 CR,是通过HO-A-OH与适当的酰胺反应制得的。 Z 1 是取代的氨基的化合物HO-A-Z 1 是通过HO-A-卤素与适当的胺反应制得的。通过使NH 2 -A-OH.HCl与SOCl 2反应来制备化合物NH 2 -A-Cl.HCl。化合物R 4 COCH 2 CO 2 -A-Z 1 是通过Dorsch等人,J.Am.Chem.Soc。,Vol.26,Vol.9,J.Am.Chem.Soc。,Vol.2,pp.1,2,3,4,6,9,9,9,9,9,13,18,18,16的反应制备的。化学Soc.54,2960(1932)。通过在正丁基锂的存在下,使合适的2-甲基-1,3-氧杂氮杂环化合物与R 4 COCl反应制备化合物XIII。通过HOANH 2与乙酸反应制备化合物XIV。通过使H 2 N-A-NHR 1与乙酸反应来制备化合物XV。通过C1-A-Cl与硫代乙酰胺的反应制备化合物XVI。通过使2-氰基化合物与乙醇反应来制备化合物XVII。通过使2-甲基化合物与R 2 COCl和正丁基锂反应来制备化合物XVIII。化合物XIX是通过R 2 COCH 2 CN与适当的苯并呋喃喃反应制备的。药物组合物包含化合物I,II或IIA以及合适的载体,并且可用作抗菌剂。

著录项

  • 公开/公告号NL7808008A

    专利类型

  • 公开/公告日1978-11-30

    原文格式PDF

  • 申请/专利权人 PFIZER INC. TE NEW YORK.;

    申请/专利号NL19780008008

  • 发明设计人

    申请日1978-07-28

  • 分类号A61K31/495;C07D241/52;

  • 国家 NL

  • 入库时间 2022-08-22 20:41:37

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号